Stendra

Stendra Patient Assistance Program Guide: How to Get Stendra (avanafil) at Low or No Cost

Important Notice: As of March 2026, Petros Pharmaceuticals, the manufacturer of Stendra (avanafil), does not appear to offer a dedicated patient assistance program (PAP) for free or heavily discounted medication based on available information. Petros is actively pursuing over-the-counter (OTC) status for Stendra to increase accessibility without a prescription[1][2][5]. This guide provides general steps for seeking assistance, alternative low-cost options, and what to do if a formal PAP is unavailable. Always verify with the manufacturer or your healthcare provider for the latest details.

About Stendra (avanafil)

Stendra is a prescription medication used to treat erectile dysfunction (ED) in adult men. It belongs to a class of drugs called PDE5 inhibitors, which work by increasing blood flow to the penis during sexual stimulation, helping achieve and maintain an erection. Unlike some other ED medications, Stendra is known for its fast onset, working as quickly as 15 minutes after taking it[6].

Stendra comes in tablets of 50 mg, 100 mg, and 200 mg, taken as needed about 15-30 minutes before sexual activity. Do not take more than one dose in 24 hours. Common side effects include headache, flushing, nasal congestion, and back pain. Serious risks can include sudden vision or hearing loss, priapism (prolonged erection), or heart problems—seek immediate medical help if these occur. Always consult your doctor before starting, especially if you have heart disease, low blood pressure, or take nitrates[6].

Petros Pharmaceuticals is working toward making Stendra available over-the-counter (OTC), potentially as the first ED drug in its class without needing a prescription. This could greatly improve access, but FDA approval is pending studies on label comprehension and AI app technology[1][2][3][7][8].

Who Qualifies for Assistance?

Since no specific PAP details are available from Petros (e.g., no named program, income thresholds, or application process listed), qualification cannot be precisely defined. Typically, pharmaceutical PAPs target:

• Uninsured or underinsured patients.
• Low-income individuals/families at or below 400% of the Federal Poverty Level (FPL) (common threshold; varies by program).
• U.S. residents (often excluding certain territories).
• Valid prescription from a U.S. licensed provider.

Contact Petros directly via their website (petrospharma.com) or investor relations for any unpublicized programs[5]. In the absence of a PAP, explore generics, discount cards, or telehealth options like Lemonaid Health, which offers Stendra at reduced prices through direct manufacturer collaboration[6].

Income Eligibility Breakdown

Without program-specific data, here's a general table based on standard PAP structures (e.g., 400% FPL for 2026; actual figures adjust annually). Confirm with Petros or use tools like NeedyMeds.org.

Table is illustrative; Petros has no confirmed thresholds.

Insurance Requirements

Most PAPs require you to be uninsured, have Medicare Part D, or have commercial insurance but still face high out-of-pocket costs (e.g., after coverage gap). Medicare patients often qualify if they hit the "donut hole." Petros may exclude those with government insurance like Medicaid. If insured, exhaust copay assistance cards first. No specific insurance rules confirmed for Stendra[6].

Step-by-Step Application Process

1. Confirm Eligibility: Call Petros Pharmaceuticals at their general contact (check petrospharma.com) or email investor relations to inquire about PAP availability[5]. Ask: "Do you offer patient assistance for Stendra?"

2. Gather Documents: Prepare proof of income (tax return, pay stubs, W-2s), prescription, proof of residency, and insurance status (if applicable). No required list confirmed.

3. Apply: If a program exists, expect online, mail, or phone application. Download forms from manufacturer site if available. Telehealth like Lemonaid may bypass traditional PAPs with affordable pricing[6].

4. Submit and Follow Up: Mail/fax/email docs. Track status via phone.

5. Approval: If approved, medication ships free to your pharmacy or home.

Timeline and Delivery

Standard PAP processing: 2-4 weeks from submission to approval/denial. Delays possible with incomplete docs. Delivery via mail or pharmacy direct (1-2 weeks post-approval). No Petros-specific info; OTC pursuit may change access dynamics soon[1][2].

Alternatives if Denied or No Program Available

• Discount Cards: GoodRx, SingleCare—Stendra copays as low as $50-100 (check current prices).
• Telehealth: Lemonaid Health offers Stendra affordably[6].
• Generics: Avanafil generics may emerge; alternatives like sildenafil (Viagra generic), tadalafil (Cialis generic) cheaper.
• Patient Access Networks: NeedyMeds, RxAssist, Partnership for Prescription Assistance.
• Manufacturer Samples: Ask your doctor for free samples.
• OTC Future: Monitor Petros for Stendra OTC approval[1][2][5].

No biosimilars for Stendra currently.

Disclaimer

This guide is for informational purposes only and not medical or financial advice. Program details can change; verify directly with Petros Pharmaceuticals. Consult your healthcare provider for treatment suitability. Income estimates based on general FPL; not official. Word count: 942.